The data showed that knockdown of UBE2CP3 decreased the expression of the mesenchymal biomarkers (ZEB1 and VIM) but increased the expression of epithelial biomarkers (CDH1 and EPCAM) in GC cell lines (Fig. 3K). The gene discussed is ZEB1; the disease is gastric cancer.